37487
document
Medium chain triglyceride oil consumption as part of a weight loss diet does not lead to an adverse metabolic profile when compared to olive oil . OBJECTIVE Medium chain triglyceride ( MCT ) consumption may have a beneficial impact on weight management , however , some studies point to a negative impact of MCT oil consumption on cardiovascular disease risk . This study examined the effects of MCT oil consumption , as part of a weight loss diet , on metabolic risk profile compared to olive oil . DESIGN Thirty-one men and women , age 19-50 y and body mass index 27-33 kg/m ( 2 ) , completed this randomized , controlled , 16-week weight loss program . Oils were consumed at a level of approximately 12 % of the subjects ' prescribed energy intakes in the form of muffins and liquid oil . RESULTS After controlling for body weight , there was a significant effect of time on fasting serum glucose ( P = 0.0177 ) and total cholesterol ( P = 0.0386 ) concentrations , and on diastolic blood pressure ( P = 0.0413 ) , with reductions in these variables occurring over time ; there was no time-by-diet interaction for any of the parameters studied . Two of the 3 subjects in the MCT oil group with evidence of the metabolic syndrome at baseline did not have metabolic syndrome at endpoint . In the olive oil group , 6 subjects had the metabolic syndrome at baseline ; 2 subjects no longer had metabolic syndrome at endpoint , 1 person developed metabolic syndrome , and 4 subjects did not have any change in their metabolic syndrome status . CONCLUSIONS Our results suggest that MCT oil can be incorporated into a weight loss program without fear of adversely affecting metabolic risk factors . Distinction should be made regarding chain length when it comes to discussing the effects of saturated fats on metabolic risk factors .
37488
Intervention_Pharmacological
Medium chain triglyceride oil
37489
Intervention_Pharmacological
Medium chain triglyceride ( MCT )
37490
Intervention_Pharmacological
MCT oil
37491
Intervention_Pharmacological
MCT oil consumption
37492
Intervention_Pharmacological
liquid oil
37493
Intervention_Pharmacological
MCT oil
37494
Intervention_Pharmacological
olive oil
37495
Intervention_Pharmacological
MCT oil
37496
Outcome_Physical
fasting serum glucose
37497
Outcome_Physical
total cholesterol
37498
Outcome_Physical
diastolic blood pressure
37499
Participant_Sample-size
Thirty-one
37500
Participant_Sex
men and women
37501
Participant_Age
age 19-50 y
37502
Participant_Condition
body mass index 27-33 kg/m ( 2 )
37503
Participant_Condition
MCT oil
37504
Participant_Condition
metabolic syndrome
37505
Participant_Condition
metabolic syndrome